Literature DB >> 2581459

Permeability of blood-brain barrier to various sized molecules.

W G Mayhan, D D Heistad.   

Abstract

We studied disruption of the blood-brain barrier (BBB) by acute hypertension and a hyperosmolar solution. The goals were to determine whether 1) disruption of the BBB occurs primarily in arteries, capillaries, or veins, and 2) transport of different-sized molecules is homogeneous or size dependent. Sprague-Dawley rats were studied using intravital fluorescent microscopy of pial vessels and fluorescein-labeled dextrans (FITC-dextran, mol wt = 70,000, 20,000, and 4,000 daltons). The site of disruption was determined by the appearance of microvascular leaky sites. Transport of different-sized molecules was calculated from clearance of FITC-dextran. During gradual hypertension and osmotic disruption, all leaky sites were venular. Rapid hypertension produced venular leaky sites and, in some experiments, diffuse arteriolar extravasation of FITC-dextran. Clearance of different-sized molecules was homogeneous during acute hypertension. In contrast, clearance of molecules during osmotic disruption was size dependent. The findings suggest that 1) venules and veins are the primary sites of disruption following acute hypertension and a hyperosmolar solution; 2) transport of different-sized molecules is homogeneous following acute hypertension, which suggests a vesicular mechanism; and 3) transport following hyperosmolar disruption is size dependent, which suggests that hyperosmolar disruption may involve formation of pores as well as vesicular transport.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581459     DOI: 10.1152/ajpheart.1985.248.5.H712

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  48 in total

1.  Lack of effect of topically applied nicotine on pial arteriole diameter and blood-brain barrier integrity in the cat.

Authors:  L Schilling; A Bultmann; M Wahl
Journal:  Clin Investig       Date:  1992 Mar-Apr

2.  Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.

Authors:  A M Butt; H C Jones; N J Abbott
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

Review 3.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

4.  Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption and downregulate circulating interleukin 6 in mice.

Authors:  Aric F Logsdon; Michelle A Erickson; Xiaodi Chen; Joseph Qiu; Yow-Pin Lim; Barbara S Stonestreet; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-24       Impact factor: 6.200

Review 5.  Mouse models of neurological disorders: a view from the blood-brain barrier.

Authors:  William A Banks
Journal:  Biochim Biophys Acta       Date:  2009-10-29

6.  Computerised image analysis in conjunction with fluorescence microscopy for the study of blood-brain barrier permeability in vivo.

Authors:  A Findling; L Schilling; A Bultmann; M Wahl
Journal:  Pflugers Arch       Date:  1994-05       Impact factor: 3.657

7.  Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury.

Authors:  Sang Mi Lee; Steven Rosen; Philip Weinstein; Nico van Rooijen; Linda J Noble-Haeusslein
Journal:  J Neurotrauma       Date:  2011-08-08       Impact factor: 5.269

Review 8.  Venous system in acute brain injury: Mechanisms of pathophysiological change and function.

Authors:  Sheng Chen; Yujie Chen; Liang Xu; Nathanael Matei; Jiping Tang; Hua Feng; JohnH Zhang
Journal:  Exp Neurol       Date:  2015-03-14       Impact factor: 5.330

9.  nNOS-dependent reactivity of cerebral arterioles in Type 1 diabetes.

Authors:  Denise M Arrick; Glenda M Sharpe; Hong Sun; William G Mayhan
Journal:  Brain Res       Date:  2007-10-12       Impact factor: 3.252

Review 10.  Magnesium sulfate for the treatment of eclampsia: a brief review.

Authors:  Anna G Euser; Marilyn J Cipolla
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.